Chronic Spontaneous Uriticaria
2 clinical trials · Condition
◉ Watch Chronic Spontaneous Uriticaria
| Record | Firm | Date |
|---|---|---|
| Study of Efficacy and Safety of Omalizumab in Refractory Chronic Spontaneous Urticaria Patients (NCT02329223) | Novartis Pharmaceuticals | 2014-12-01 |
Track Chronic Spontaneous Uriticaria automatically
Every clearance here is in the API, with alerts when new ones post.